Literature DB >> 20220168

Simultaneous cocirculation of both European varicella-zoster virus genotypes (E1 and E2) in Mexico city.

Araceli Rodríguez-Castillo1, Gilberto Vaughan, José Ernesto Ramírez-González, Alejandro Escobar-Gutiérrez.   

Abstract

Full-length genome analysis of varicella-zoster virus (VZV) has shown that viral strains can be classified into seven different genotypes: European (E), Mosaic (M), and Japanese (J), and the E and M genotypes can be further subclassified into E1, E2, and M1 through 4, respectively. The distribution of the main VZV genotypes in Mexico was described earlier, demonstrating the predominance of E genotype, although other genotypes (M1 and M4) were also identified. However, no information regarding the circulation of either E genotype in the country is available. In the present study, we confirm the presence of both E1 and E2 genotypes in the country and explore the possibility of coinfection as the triggering factor for increased virulence among severe cases. A total of 61 different European VZV isolates collected in the Mexico City metropolitan area from 2005 to 2006 were typed by using a PCR method based on genotype-specific primer amplification. Fifty isolates belonged to the E1 genotype, and the eleven remaining samples were classified as E2 genotypes. No coinfection with both E genotypes was identified among these specimens. We provide here new information on the distribution of VZV genotypes circulating in Mexico City.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220168      PMCID: PMC2863930          DOI: 10.1128/JCM.00112-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  A novel mutation of varicella-zoster virus associated to fatal hepatitis.

Authors:  Silvia Natoli; Marco Ciotti; Pierpaolo Paba; Gian Piero Testore; Giampiero Palmieri; Augusto Orlandi; Alessandro Fabrizio Sabato; Francesca Leonardis
Journal:  J Clin Virol       Date:  2006-07-28       Impact factor: 3.168

3.  Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain.

Authors:  Vladimir Loparev; Elisa Martro; Elena Rubtcova; Carlos Rodrigo; Jean-Charles Piette; Eric Caumes; Jean-Paul Vernant; D Scott Schmid; Anne-Marie Fillet
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

4.  New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray.

Authors:  Nikolay Sergeev; Elena Rubtcova; Vladimir Chizikov; D Scott Schmid; Vladimir N Loparev
Journal:  J Virol Methods       Date:  2006-05-03       Impact factor: 2.014

5.  Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.

Authors:  Myron J Levin; Roberta L DeBiasi; Vanda Bostik; D Scott Schmid
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

6.  Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.

Authors:  Vladimir N Loparev; Elena N Rubtcova; Vanda Bostik; Dhwani Govil; Christopher J Birch; Julian D Druce; D Scott Schmid; Margaret C Croxson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

7.  End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions.

Authors:  Sumathi Ramachandran; Guo-Liang Xia; Lilia M Ganova-Raeva; Omana V Nainan; Yury Khudyakov
Journal:  J Virol Methods       Date:  2008-06-20       Impact factor: 2.014

8.  Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.

Authors:  Sandra S Chaves; Penina Haber; Kimp Walton; Robert P Wise; Hector S Izurieta; D Scott Schmid; Jane F Seward
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

9.  Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Adolfo Martínez-Palomo; Graciela Ordoñez; Benjamin Pineda
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

10.  Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.

Authors:  Adriana S Lopez; Andrea Burnett-Hartman; Ram Nambiar; Linda Ritz; Patricia Owens; Vladimir N Loparev; Dalya Guris; D Scott Schmid
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

View more
  6 in total

1.  Interleukin-28B genotyping by melt-mismatch amplification mutation assay PCR analysis using single nucleotide polymorphisms rs12979860 and rs8099917, a useful tool for prediction of therapy response in hepatitis C patients.

Authors:  Salvador Fonseca-Coronado; Gilberto Vaughan; Mayra Yolanda Cruz-Rivera; Juan Carlos Carpio-Pedroza; Karina Ruiz-Tovar; Juan Alberto Ruiz-Pacheco; Alejandro Escobar-Gutiérrez
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

2.  Specific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naïve infected individuals.

Authors:  Salvador Fonseca-Coronado; Alejandro Escobar-Gutiérrez; Karina Ruiz-Tovar; Mayra Yolanda Cruz-Rivera; Pilar Rivera-Osorio; Mauricio Vazquez-Pichardo; Juan Carlos Carpio-Pedroza; Juan Alberto Ruíz-Pacheco; Fernando Cazares; Gilberto Vaughan
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

3.  Is ultra-violet radiation the main force shaping molecular evolution of varicella-zoster virus?

Authors:  Gilberto Vaughan; Araceli Rodríguez-Castillo; Mayra Y Cruz-Rivera; Karina Ruiz-Tovar; José E Ramírez-González; Pilar Rivera-Osorio; Salvador Fonseca-Coronado; Juan C Carpio-Pedroza; Fernando Cazares; Mauricio Vazquez-Pichardo; Luis Anaya; Alejandro Escobar-Gutiérrez
Journal:  Virol J       Date:  2011-07-27       Impact factor: 4.099

4.  Melt analysis of mismatch amplification mutation assays (Melt-MAMA): a functional study of a cost-effective SNP genotyping assay in bacterial models.

Authors:  Dawn N Birdsell; Talima Pearson; Erin P Price; Heidie M Hornstra; Roxanne D Nera; Nathan Stone; Jeffrey Gruendike; Emily L Kaufman; Amanda H Pettus; Audriana N Hurbon; Jordan L Buchhagen; N Jane Harms; Gvantsa Chanturia; Miklos Gyuranecz; David M Wagner; Paul S Keim
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

5.  Varicella Outbreak in an Indian Couple Living in Germany Caused by VZV Clade VI Acquired during a Trip to The Netherlands.

Authors:  Malgorzata Kolesnik; Bernd Bonnekoh; Ina Tammer; Harald Gollnick; Andreas Sauerbrei
Journal:  Case Rep Med       Date:  2012-03-14

6.  Vaccine Strain and Wild-Type Clades of Varicella-Zoster Virus in Central Nervous System and Non-CNS Disease, New York State, 2004-2019.

Authors:  Patrick Bryant; Tugba Yildirim; Sara B Griesemer; Kara Shaw; Dylan Ehrbar; Kirsten St George
Journal:  J Clin Microbiol       Date:  2022-03-24       Impact factor: 11.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.